Regenerative medicine as a disruptive technology: implications for manufacturing & clinical adoption (2019)

First Author: Banda G
Attributed to:  SynthSys-Mammalian: Edinburgh Mammalian Synthetic Biology Research Centre funded by BBSRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.18609/cgti.2019.135

Publication URI: http://dx.doi.org/10.18609/cgti.2019.135

Type: Journal Article/Review

Parent Publication: Cell and Gene Therapy Insights

Issue: 10